Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.54 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.54 |
| ▸ | NPC1 | O15118 | 2/20 | 0.51 |
| ▸ | RAB9A | P51151 | 2/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | PRKDC | P78527 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14937681 | 0.88 | ALDH1A1 (0.43) | ALDH1A1CYP2D6L3MBTL1NPC1RAB9A | |
| SCHEMBL27982502 | 0.84 | RAB9A (0.50) | ALDH1A1CYP2D6L3MBTL1NPC1RAB9A | |
| SCHEMBL3645769 | 0.82 | ALDH1A1 (0.59) | ALDH1A1CYP2D6L3MBTL1NPC1RAB9A | |
| SCHEMBL124590 | 0.82 | ALDH1A1 (0.63) | ALDH1A1CYP2D6L3MBTL1NPC1RAB9A | |
| SCHEMBL4043187 | 0.81 | ALDH1A1 (0.57) | ALDH1A1CYP2D6L3MBTL1NPC1RAB9A | |
| SCHEMBL18040256 | 0.80 | RAB9A (0.49) | ALDH1A1CYP2D6L3MBTL1NPC1RAB9A | |
| SCHEMBL40798 | 0.79 | ALDH1A1 (0.56) | ALDH1A1CYP2D6L3MBTL1NPC1RAB9A | |
| SCHEMBL5058658 | 0.79 | ALDH1A1 (0.56) | ALDH1A1CYP2D6L3MBTL1NPC1RAB9A | |
| SCHEMBL1261460 | 0.79 | ALDH1A1 (0.56) | ALDH1A1CYP2D6L3MBTL1NPC1RAB9A | |
| SCHEMBL66837 | 0.79 | ALDH1A1 (0.56) | ALDH1A1CYP2D6L3MBTL1NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117813550-A | Photosensitive surface treating agent, laminate, transistor, pattern forming method, and method for manufacturing transistor | 株式会社尼康 | 2024-04-02 | — | — | CN | disclosed |
| US-20230373962-A1 | SUPRAMOLECULAR MOLECULES FOR THE TREATMENT OF CANCER | THE UNIVERSITY OF BIRMINGHAM (GB) | 2023-11-23 | — | — | US | disclosed |
| WO-2023022042-A1 | PHOTOSENSITIVE SURFACE TREATMENT AGENT, LAMINATE, TRANSISTOR, PATTERN FORMATION METHOD, AND TRANSISTOR MANUFACTURING METHOD | 株式会社ニコン | 2023-02-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230373962-A1 | SUPRAMOLECULAR MOLECULES FOR THE TREATMENT OF CANCER | PCNA, DDX1, DDX18 | ALDH1A1 4454/4885CYP2D6 3804/4885L3MBTL1 3420/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.